Rivaroxaban for thromboprophylaxis in cancer patients | New England Journal of Medicine - MD Linx

Rivaroxaban for thromboprophylaxis in cancer patients | New England Journal of Medicine  MD Linx

Internal Medicine Article: Rivaroxaban for thromboprophylaxis in high-risk ambulatory patients with cancer.



Comments

Popular posts from this blog

Anand Swaminath, MD, Discusses Rationale for Assessing SBRT Vs CRT in Central/Peripheral NSCLC - Cancer Network